MGMT promoter methylation in Peruvian patients with glioblastoma

PURPOSE: O(6)-methylguanine–DNA methyltransferase (MGMT) promoter methylation predicts the outcome and response to alkylating chemotherapy in glioblastoma. The aim of this study is to evaluate the prevalence of MGMT methylation in Peruvian glioblastoma cases. PATIENTS AND METHODS: We evaluated retro...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Ecancermedicalscience
Glavni autori: Belmar-Lopez, Carolina, Castaneda, Carlos A, Castillo, Miluska, García-Corrochano, Pamela, Orrego, Enrique, Meléndez, Barbara, Casavilca, Sandro, Flores, Claudio
Format: Artigo
Jezik:Inglês
Izdano: Cancer Intelligence 2018
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5834313/
https://ncbi.nlm.nih.gov/pubmed/29515653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2018.812
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items